evolocumab
Appearance
English
[edit]Etymology
[edit]From [Term?] + -c- (“cardiovascular”) + -umab (“human monoclonal antibody”).
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Pronunciation
[edit]- (General American) IPA(key): /ˌɛv.əˈlɑk.jəˌmæb/
Noun
[edit]evolocumab (uncountable)
- (pharmacology) A human monoclonal antibody designed for the treatment of hyperlipidemia.
- 2015 July 24, Andrew Pollack, “New Drug Sharply Lowers Cholesterol, but It’s Costly”, in New York Times[1]:
- So was Repatha, or evolocumab, a similar drug developed by Amgen that is expected to win F.D.A. approval by the end of August.